Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Neoplasms, Hormone-Dependent × Estrogen Receptor Modulators × Clear all

Phase

Status

Terminated 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Neoplasms, Hormone-Dependent 1 Carcinoma, Lobular 1 Carcinoma, Ductal, Breast 1 Breast Neoplasms 1

Interventions

atamestane 1 Toremifene 1 Sunitinib 1 Self-Management 1 Letrozole 1 Estrogen Receptor Modulators 1 Aromatase Inhibitors 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00044291 2015-07-31

Phase III Study of Atamestane Plus Toremifene Versus Letrozole in Advanced Breast Cancer

Intarcia Therapeutics

Phase 3 Completed

Breast Neoplasms, Neoplasms, Hormone-Dependent, Carcinoma, Ductal, Breast, Carcinoma, Lobular

Data powered by HemOnc (CC BY 4.0) Colophon ⚡